Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Choline”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,081 records · Page 60Linked to original sources

In vivo and in vitro evidence for a common carrier mediated transport of choline and basic drugs through the blood-brain barrier.

The blood-brain barrier (BBB) transport system for choline and basic drugs was characterized by the in vivo carotid artery injection technique (Oldendorf, Brain Res., 24, 372-376, 1970) and in vitro uptake into isolated bovine brain capillaries (Pardridge et al., J. Neurochem., 44, 1178-1184, 1985). Basic drugs such as eperisone, thiamine and scopolamine significantly inhibited choline uptake by the BBB with the half inhibitory concentration, IC50 value of 1.45, 2.06, and 0.47 mM, respectively. On the contrary, the uptake of choline was not inhibited by amino acids (L-phenylalanine and L-arginine) and acidic drugs (nicotinic acid, salicylic acid and valproic acid). Choline was taken up by the isolated brain capillaries in concentration and temperature dependent manners. The uptake of choline by the isolated bovine brain capillaries was significantly inhibited by eperisone, scopolamine and thiamine in consistent with the in vivo results. Furthermore, eperisone inhibited competitively the uptake of choline with the inhibition constant, Ki value of 455 microM. According to these results it was suggested that in the BBB choline and basic drugs would share a common carrier-mediated transport system.

Animals↗

Effects of idebenone (CV-2619) on the concentrations of acetylcholine and choline in various brain regions of rats with cerebral ischemia.

The concentrations of acetylcholine (Ach) and choline in various brain regions of rats with and without cerebral ischemia and the effects of 6-(10-hydroxy-decyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone (idebenone, CV-2619) on the levels of these parameters were investigated. Cerebral ischemia was induced by a 200-sec occlusion of both common carotid arteries in animals in which both vertebral arteries had been permanently cauterized. The concentrations of Ach and choline in the brain were determined by means of pyrolysis gas chromatography. In normal rats, CV-2619 (10, 30 and 100 mg/kg, i.p.) did not alter the concentrations of Ach and choline in the brain regions examined. In the ischemic rats, a significant decrease in Ach and a marked increase in choline were observed in the cerebral cortex, hippocampus, striatum, and diencephalon. A slight increase in the concentration of choline was also observed in the cerebellum and brain stem. Pretreatment with CV-2619 (10 mg/kg, i.p.) inhibited the decrease in Ach and the increase in choline in the forebrain regions. Moreover, the same dose of CV-2619 inhibited the increment of lactate content and tended to inhibit the decrement of ATP content in the cerebral cortex. These results indicate that CV-2619 inhibits alterations of the concentrations of Ach and choline in the brain of the ischemic rats; this inhibition may be due to the ameliorating effect of CV-2619 on the disturbance of cerebral energy metabolism under ischemic conditions.

Acetylcholine↗

Different response to choline deficiency of the serum ornithine carbamoyltransferase activity in four strains of rats.

Rats of the Donryu, Wistar, Fischer, and Sprague-Dawley strains were examined for the effects of choline deficiency on liver lipids, serum lipids, and serum ornithine carbamoyltransferase. The liver total lipid, triacylglycerol, cholesterol and phospholipid contents in the choline-deficient rats were significantly higher than those in choline-sufficient rats. The contents of total lipids and phospholipids in the liver of the Wistar and Fischer rats fed on a choline-deficient diet were significantly higher than those of the Donryu and Sprague-Dawley rats. The levels of triacylglycerol, cholesterol and phospholipids in the serum were significantly decreased by feeding with the choline-deficient diet. The serum ornithine carbamoyltransferase activity was increased in the Wistar and Fischer strains by feeding with the choline-deficient diet. The Wistar and Fischer strains were consequently the most sensitive to both lipid accumulation and liver lesions induced by the choline deficiency.

Animals↗

Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry.

BACKGROUND: The quaternary ammonium compounds, choline and betaine, and dimethylglycine (DMG) reside along a metabolic pathway linked to the synthesis of neurotransmitters and membrane phospholipids and to homocysteine remethylation and, therefore, folate status. Lack of a convenient, high-throughput method for the determination of these compounds has prevented population-based studies of their possible associations with lifestyle, nutrition, and chronic diseases. METHODS: Serum or plasma samples were deproteinized by mixing with three volumes of acetonitrile that contained d(9)-choline and d(9)-betaine as internal standards. We used a normal-phase silica column for the separation of choline (retention time, 2.8 min), betaine (1.3 min), DMG (1.15 min), and internal standards, which were detected as positive ions by tandem mass spectroscopy in the multiple-reaction monitoring mode, using the molecular transitions m/z 104-->60 (choline), m/z 113-->69 (d(9)-choline), m/z 118-->59 (betaine), m/z 127-->68 (d(9)-betaine), and m/z 104-->58 (DMG). RESULTS: For all three metabolites, the assay was linear in the range 0.4-400 micromol/L, and the lower limit of the detection (signal-to-noise ratio = 5) was < or =0.3 micromol/L. The within- and between-day imprecision (CVs) was 2.1-7.2% and 3.5-8.8%, respectively. The analytical recovery was 87-105%. The fasting plasma concentrations (median, 25th-75th percentiles) were 8.0 (7.0-9.3) micromol/L for choline, 31.7 (27.0-41.1) micromol/L for betaine, and 1.66 (1.30-2.02) micromol/L for DMG in 60 healthy blood donors. In individuals who had eaten a light breakfast, plasma concentrations of all three metabolites were significantly (25-30%) higher than in fasting individuals. CONCLUSION: This is the first method for the combined measurement of choline, betaine, and DMG in human plasma or serum. The assay is characterized by simple sample preparation, no derivatization, high throughput, imprecision (CV) <10%, detection limits below the values seen in volunteers, and the high specificity provided by tandem mass spectroscopy.

Adult↗

An economical assay for HDL phosphatidyl choline.

An economical enzymatic assay for HDL phosphatidyl choline is described, as adapted for the Cobas-Bio analyser (Hoffmann LaRoche). This method entails the enzymatic cleavage of phosphatidyl choline by phospholipase C from B. cereus, hydrolysis of phosphoryl choline and enzymatic determination of choline with choline oxidase by an enzymatic colour test. This method provides consistent values and is, by comparison to the enzymatic UV method (assaying choline with choline kinase in an optical test procedure), simpler to perform, more precise, and less expensive.

Alcohol Oxidoreductases↗

Declines in serum free and bound choline concentrations in humans after three different types of major surgery.

We examined the changes in circulating choline status in humans in response to major surgery by measuring serum free and phospholipid-bound choline concentrations before, during and 1-72 h after total abdominal hysterectomy, off-pump coronary artery graft surgery or brain tumor surgery. Preoperatively, the mean serum free and phospholipid-bound choline concentrations in patients scheduled for abdominal hysterectomy (n = 26), off-pump coronary artery grafting surgery (n = 34) or brain tumor surgery (n = 24) were 12.3 +/- 0.5, 12.1 +/- 0.4 and 11.4 +/- 0.4 micromol/l, and 2495 +/- 75, 2590 +/- 115 and 2625 +/- 80 micromol/l, respectively. Serum free choline and phospholipid-bound choline concentrations decreased from these baseline values to 8.8 +/- 0.7 (p < 0.001), 8.8 +/- 0.5 (p < 0.001) and 8.2 +/- 0.4 micromol/l (p < 0.001), and 2050 +/- 108 (p < 0.001), 2166 +/- 59 (p < 0.001) and 1884 +/- 104 micromol/l (p < 0.001) at 1 h after hysterectomy, off-pump bypass graft surgery or brain tumor surgery, respectively. They remained at these low levels for 24 h and then gradually increased towards the preoperative values at 48-72 h postoperatively. Serum cortisol increased postoperatively in all surgical patients for 24 h and its levels were inversely correlated with serum free and bound choline concentrations. These results show that circulating free and bound choline concentrations decrease for 72 h after total abdominal hysterectomy, off-pump coronary artery graft surgery or brain tumor surgery in humans.

Adult↗

Choline metabolism in cancer: implications for diagnosis and therapy.

Magnetic resonance studies from the last 10 years have conclusively demonstrated that choline metabolism is altered in a wide variety of cancers. In cancer, the choline metabolite profile is characterized by an elevation of phosphocholine and total choline-containing compounds. This elevation is increasingly being used as an endogenous biomarker of cancer. Importantly, the enzymes and pathways resulting in these distinct alterations in phosphocholine and total choline may provide novel molecular targets for specific, targeted anticancer therapies. In this article, we have summarized some of the magnetic resonance spectroscopy and positron emission tomography techniques that are currently available, or will be in the near future, for choline metabolism-based diagnosis, staging and therapy assessment in cancer patients. This review also outlines currently known molecular alterations that cause the aberrant choline metabolite profile in cancers and concludes with a summary of recent research findings that may, in the future, lead to novel anticancer therapies targeting choline metabolism.

Animals↗

Choline supplementation facilitates short-term memory consolidation into intermediate long-term memory of young Sprague-Dawley rats.

Choline is important for the synthesis of acetylcholine, an integral neurotransmitter involved in memory formation. In order to investigate the effect of choline supplementation on memory consolidation, the study utilized a T-maze to facilitate passive avoidance learning and memory in young female Sprague-Dawley rats. Rats were placed in two groups; choline-supplemented that received choline chloride daily for two weeks, and control that received vehicle daily for two weeks. Rats were evaluated to determine their ability to avoid an aversive electric foot-shock (0.1 mA at 60V) when they characteristically entered the preferred dark area (DA) of the T-maze. Both groups of rats showed preference, without significant difference, for entry into DA of the T-maze. However, fifteen minutes after passive avoidance both choline supplemented and control rats avoided entry into DA. This display of DA avoidance 15 minutes after training, suggests that both groups of rats had acquired short-term memory of the aversive stimulus. However, when the test was repeated 24 hours after training, the control group did not avoid entry into DA, whereas the choline-supplemented group either avoided entry or entered after a significantly longer latency period (p < 0.01). These results suggest that supplementation with choline facilitated the consolidation of short-term memory of the avoidance learning into intermediate long-term memory in young rats.

Age Factors↗

Infected erythrocyte choline carrier inhibitors: exploring some potentialities inside Plasmodium phospholipid metabolism for eventual resistance acquisition.

We have developed a model for designing antimalarial drugs based on interference with an essential metabolism developed by Plasmodium during its intraerythrocytic cycle, phospholipid (PL) metabolism. The most promising drug interference is choline transporter blockage, which provides Plasmodium with a supply of precursor for synthesis of phosphatidylcholine (PC), the major PL of infected erythrocytes. Choline entry is a limiting step in this metabolic pathway and occurs by a facilitated-diffusion system involving an asymmetric carrier operating according to a cyclic model. Choline transport in the erythrocytes is not sodium dependent nor stereospecific as demonstrated using stereoisomers of alpha and beta methylcholine. These last two characteristics along with distinct effects of nitrogen substitution on transport rate demonstrate that choline transport in the infected erythrocyte possesses characteristics quite distinct from that of the nervous system. This indicates a possible discrimination between the antimalarial activity (inhibition of choline transport in the infected erythrocyte) and a possible toxic effect through inhibition of choline entry in synaptosomes. Apart from the de novo pathway of choline, PC can be synthesized by N-methylation from phosphatidylethanolamine (PE). There is a de novo pathway for PE biosynthesis from ethanolamine in infected cells but phosphatidylserine (PS) decarboxylation also occurs. In addition, PE can be directly and abundantly synthesized from serine decarboxylation into ethanolamine, a pathway which is absent from the host. The variety of the pathways that exist for the biosynthesis of one given PL led us to investigate whether an equilibrium can occur between all PL metabolic pathways.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

Blood-brain barrier choline transport is reduced in diabetic rats.

The kinetics of blood-brain barrier (BBB) choline transport in streptozocin-induced diabetic rats were compared with those of age-matched vehicle-injected control rats. The brain uptake index (BUI) of choline in diabetic rats (13.9 +/- 1.1%) was significantly lower than that in control rats (22.6 +/- 0.7%) (P less than .05). This alteration in brain choline uptake appeared to occur in long-standing (9 wk) diabetes. Thus, acute hyperglycemia and diabetes mellitus for shorter periods (3 wk) did not significantly alter the BUI of choline. Insulin (8 U/kg) treatment for 5 days did not alter BUI in diabetic rats (12.9 +/- 0.9%). The maximal velocity of BBB choline transport (Vmax) in diabetic rats (0.14 +/- 0.07 nmol . min-1 . g-1) was significantly lower than the Vmax in control rats (2.2 +/- 0.8 nmol . min-1 . g-1) (P less than .05). The Km of choline transport in diabetic rats (120 +/- 70 microM) was modestly but not significantly lower than that in control animals (400 +/- 160 microM). Similarly, the constant of the nonsaturable component of the transport (Kd) in diabetic animals (0.5 +/- 0.07 microliter . min-1 . g-1) was not significantly different from that in control rats (0.9 +/- 0.3 microliter . min-1 . g-1). The data indicate that diabetes mellitus in rats is associated with a decreased BBB choline transport.

Animals↗

The influence of sow dietary lipids and choline on piglet survival, milk and carcass composition.

Twenty-one crossbred gilts and 75 crossbred sows were randomly assigned to six treatments for examination of the effect of lipid feeding and choline level on baby pig survival. Dietary variables were supplemental fat and choline in a 3 X 2 factorial arrangement. Fat treatments were no supplemental fat, 10% corn oil and 10% animal fat; choline treatments were 0 and 500 ppm supplemental choline from choline chloride. Baby pig survival and litter weight at 21 days were improved (P less than .05) by supplemental fat. Lipid treatments also improved (P less than .05) percentage survival among piglets in the weight ranges of 909 g or less, 1,136 to 1,362 g and 1,363 to 1,589 grams. Lipid feeding increased survival by 18.5% among the piglets weighing less than 909 grams. Piglets fasted for 60 hr had 47.7% less (P less than .05) total lipids and 90.5% less (P less than .05) glycogen than 12-hr-old, nonfasted piglets. The feeding of corn oil significantly affected percentages of carcass fatty acids. Percentages of palmitic, palmitoleic, oleic and linoleic acids decreased during fasting, indicating good utilization, while percentages of stearic and arachidonic acids increased, indicating poorer utilization during fasting. Milk from control sows, which had received a gestation diet containing 4% added poultry fat prior to treatment, was only slightly lower in energy and lipid content (nonsignificant) than milk from sows on the lipid treatment. Corn oil affected (P less than .05) the percentage of fatty acids in milk. Additional choline appeared to have no beneficial effect in any phase of the experiment. Choline did not increase lipid mobilization or piglet survival.

Animals↗

Effect of tallow and choline chloride addition to the diet of sows milk composition, milk yield and preweaning pig performance.

Four trials were conducted with a total of 188 crossbred sows to determine the effect of feeding diets supplemented with tallow (0 or 8%) and choline chloride (220 or 770 mg/kg diet) prior to parturition and during lactation on preweaning pig performance. On d 100 of gestation, sows were allotted to four factorially arranged dietary treatments: 0% tallow-220 mg/kg choline chloride, 0% tallow-770 mg/kg choline chloride, 8% tallow-220 mg/kg choline chloride, 8% tallow-770 mg/kg choline chloride. Diets without tallow were fed at the rate of 1.82 kg/d with an additional .18 kg/d of cornstarch, whereas sows receiving diets supplemented with tallow were fed 1.82 kg/d. Daily metabolizable energy intake was constant for all diets (approximately 6,240 kcal). Following parturition, the diets were fed ad libitum for a 21-d lactation period. Pig survival to 21 d, in relation to the number of pigs born alive/litter, did not differ significantly between litters from sows receiving tallow (94.0%) and litters from sows receiving the control diet (92.5%). Although not significantly different, there was a trend toward slightly heavier pigs (6.35 vs 6.11 kg) and litters (53.97 vs 51.94 kg) after the 21-d lactation period in the groups nursing sows receiving tallow-supplemented diets. Litter performance was not improved by the addition of choline to sows' diets. A second study was conducted to measure the effect of energy source on milk yield and composition. Twelve crossbred sows was allotted to two dietary treatments (0 and 8% tallow), each supplemented with 770 mg choline chloride/kg of diet. The composition of colostrum and milk was determined on d 0, 9 and 18, and milk yield was measured on d 12 and 19. Throughout the lactation period, sows fed the tallow supplemented diet produced higher concentrations of total milk solids (22.15%, P less than .10) and fat (14.9%, P less than .01) than the control group (21.37 and 12.0%, respectively). Milk protein content, averaged over the lactation period, was lower (P less than .10) for sows receiving tallow (8.60 vs 9.22%); however, the depression appeared to be related to the colostrum samples, because values for the two treatment groups were similar on d 9 and 18. The mean milk yield was 9.44 kg/d for sows receiving tallow and 8.72 kg/d for those fed the control diet. Therefore, not only did sows in the tallow group produce a greater concentration of milk solids and fat, but the total quantity of the milk constituents available to the offspring was increased.

Animals↗

Excess supplemental choline for swine.

Seven experiments were conducted with 280 crossbred pigs to investigate the effect of excess choline on rate and efficiency of gain of weanling, growing and finishing swine Choline additions were made to a conventional corn-soybean meal diet. Daily gain of weanling pigs was reduced slightly by 6,000 ppm excess choline compared with 0, 500, 1,000, 2,000 or 4,000 ppm excess choline. Excess supplemental choline (2,000 ppm) fed throughout the weanling, growing and finishing (121 to 126 d) phases of growth reduced (P less than .08) daily gain but it did not affect (P greater than .10) feed utilization. The 2,000-ppm choline addition, however, did not affect (P less than .10) pig gain when fed only during the growing and finishing stages of growth (68 to 86 d). Excess choline should be avoided in swine diets if maximum rate of gain is to be achieved.

Animals↗

New insight into the biochemical pathology of liver in choline deficiency.

A diet deficient in choline can cause liver cancer in rats. The previous work since 1932 emphasized the fat-removing ability of choline from the liver. There are other dietary factors, including methionine, which, like choline, can remove fat from the liver. These factors were termed as lipotropes. Since then, choline deficiency and lipotrope deficiency are used synonoumously. Recent work since 1980 has clearly demonstrated that choline deficiency (CD) and lipotrope deficiency (LD) are not the same. Generation of free radicals, DNA alterations, liver cell death, and liver cancer that occur due to CD are not generated by LD. Generation of free radicals due to CD diet and some of the agents that counteract free radical action also prevent CD effects except for lipid accumulation in the liver. Despite the recent observations on the role of phospholipase A2 (PLA2) as the protector of the membranes, it has been found that by preventing the rise of PLA2 in the liver, cell death can be prevented. These new findings give choline a distinct role in liver cell death and cancer rather than the role of lipotrope. A new hypothesis linking dietary choline deficiency and liver cancer has been discussed.

Animals↗

Dietary choline for the lactating cow: possible effects on milk fat synthesis.

Two experiments with low forage diets tested effects of added dietary choline on milk fat synthesis. In Experiment 1, 18 Holstein cows were in a 12-wk trial. Choline (0, 1.5, and 3 g/kg) was added to the concentrate portion of a 70% concentrate, 30% corn silage diet (dry matter). Treatments were applied in a switchback design with 4-wk experimental periods. Highest choline increased milk fat by .34 percentage units and fat-corrected milk by 2 kg per day over controls. Rumen pH and volatile fatty acids were similar among treatments. Free fatty acids of blood serum were reduced 3.0 mg/100 ml by 3 g/kg choline. In Experiment 2 with four mature Holsteins, choline was added (0, 2, 4, and 6 g/kg concentrate) in 25% corn silage and 75% concentrate diets. Treatments were applied in a 4 x 4 Latin square design. Addition of 4 g/kg choline resulted in 3.7 kg/day and .77 percentage unit increases of fat-corrected milk and milk fat percent, respectively, whereas fat-corrected milk and milk fat percent at 6 g/kg were only slightly higher than controls. We hypothesized that choline aided transport of mobilized free fatty acids from adipose tissue through the liver to the mammary gland.

Animals↗

Effects of choline deficiency and phosphatidylcholine on fat absorption in rats.

Transfer of lipid to the lymph by the intestine was studied in rats fed on choline-deficient or choline-supplemented diet for 2 weeks. In choline-deficient rats, lymph output was reduced. Choline deficiency impaired the incorporation of glycerol tri[1-14C]oleate into triglyceride in the lymph. The triglyceride level in lymph lipoproteins was lower in choline-deficient rats than in controls. Ultrastructural studies suggested that impaired release of lipoproteins was responsible for accumulation of fat in intestinal absorptive cells. These defects are probably related to changes in the membrane system of the intestine and to a failure in lipid droplet movement within absorptive cells, resulting from alterations in the microfilaments. Oral administration of phosphatidylcholine to rats on choline-deficient diet rapidly improved the decreased lymph output and the impaired incorporation of glycerol tri[1-14C]oleate into triglyceride and reduced fat deposition in intestinal epithelial cells. In conclusion, phospholipids such as choline are confirmed as being extremely important in the absorption of fat by the possible mechanism of fat transport across the membrane.

Animals↗

The choline requirement of broiler chicks during the seventh week of life.

Male crossbred chicks were used to quantify the choline requirement and choline-sparing value of methionine and betaine for broiler chicks during the seventh week of life. The sulfur amino acid (SAA) requirement of male and female chicks was also determined. In all assays a crystalline amino acid diet containing 14.9% protein equivalent and 3400 kcal. M.E./kg, was employed. Increasing increments (0.08%) of SAA (equal mixture of DL-methionine and L-cystine) were fed from 0.38 to 0.70% of the diet. Least squares analysis indicated SAA requirements for maximal weight gain of 0.61 and 0.62% of the diet for males and females, respectively. The choline requirement was determined by feeding six levels of choline in the presence of 0.62% SAA. Gain but not gain/feed responded linearly to choline addition. Least squares analysis of gain indicated a dietary choline requirement of 358 p.p.m. of 30.6 mg./day. The choline-replacement value of methionine and betaine was found to be minimal.

Age Factors↗

Response of laying hens to choline when fed practical diets devoid of supplemental sulfur amino acids.

Two experiments were conducted with White Leghorn laying hens. In both experiments, a corn-soybean meal basal diet was used, and hens were housed individually in cages in open-type houses. In Experiment 1, the basal diet contained no supplemental choline, inorganic sulfate, or sulfur amino acids and was supplemented with 0 or 660 mg choline/kg, and 0 and .1% K2SO4, or K2Mg(SO4)2. In Experiment 2, the basal diet contained .1% reagent grade K2SO4. Four diets were formulated to contain 0, 110, 220, and 440 mg choline/kg, respectively. A fifth diet was formulated to contain 440 mg choline/kg and .15% DL-methionine. In Experiment 1, a significant increase in egg production resulted from supplementing the diet with 660 mg choline/kg in the absence of supplemental inorganic sulfate and sulfur amino acids. Only a numerical increase in egg production resulted from adding inorganic sulfate alone or in combination with choline. Addition of choline and inorganic sulfate in combination resulted in an increase in egg weight. In Experiment 2, 220 mg of supplemental choline/kg, or 114 mg choline intake/bird/day, resulted in maximum egg production and feed efficiency. However, maximum egg size was obtained only when supplemental DL-methionine and choline were present. The results obtained in this study indicate that laying hens will respond to supplemental choline in practical situations when diets are deficient in total sulfur amino acids, and daily sulfur amino acid intake is insufficient to meet the animal's requirement. For maximum egg size, adequate sulfur amino acids must be present in the diet, because supplementing choline alone will not maximize egg size.

Amino Acids, Sulfur↗